The potential value of combining these therapies lies in addressing overlapping cardiorenal and metabolic risk pathways as available evidence for dual therapy in HF populations remains limited and is derived largely from subgroup analyses, observational studies, and extrapolation from diabetes or obesity trials rather than dedicated HF randomized trials [24, 25, 27, 30, 50]
Daily Value not established, daily, artificial sweetener, artificial dute notificial flavors, agave, artificia preservatives and salicylates
inhibits NF-B signaling
The dosage may vary based on individual factors such as the severity of the condition and how you respond to treatment
Additionally, prolonged retention of food in the stomach may alter normal digestive processes, potentially affecting gas distribution within the gastrointestinal tract